Colgate-Palmolive (CL) call put ratio 4.3 calls to 1 put with focus on July 26 weekly calls
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil surge keeps S&P 500, Nasdaq in check before earnings; Salesforce lifts Dow
- Oil prices rise as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Colgate-Palmolive Company (CL) PT Raised to $115 at TD Cowen
July 29, 2024 1:10 PM EDTTD Cowen analyst Robert Moskow raised the price target on Colgate-Palmolive Company (NYSE: CL) to $115.00 (from $110.00) while maintaining a Buy rating.
The analyst comments "Colgate delivered a high quality 2Q and raised guidance meaningfully. Consistent with our positive thesis, volume growth continued to... More
Colgate-Palmolive Company (CL) PT Raised to $101 at Jefferies
July 29, 2024 6:06 AM EDTJefferies analyst Kaumil Gajrawala raised the price target on Colgate-Palmolive Company (NYSE: CL) to $101.00 (from $95.00) while maintaining a Hold rating.
The analyst comments "Colgate had to deliver a perfect qtr to sustain its 27x NTM P/E multiple. They did. Brand reinvestments are working,... More
Colgate-Palmolive Company (CL) PT Raised to $112 at Evercore ISI
July 29, 2024 5:34 AM EDTEvercore ISI analyst Robert Ottenstein raised the price target on Colgate-Palmolive Company (NYSE: CL) to $112.00 (from $106.00) while maintaining a Outperform rating.
The analyst comments "Friday, Colgates shares closed at a 30% premium to Staples, 5 points above its 20-year trading range. We do not expect CL to regress... More
Stifel on Colgate-Palmolive Company (CL): 'Lifting Estimates on Solid 2Q with Volume, EBIT Outperformance'
July 26, 2024 2:20 PM EDTStifel analyst Mark Astrachan reiterated a Buy rating and $105.00 price target on Colgate-Palmolive Company (NYSE: CL).
The analyst comments "We lift 2024-2025 EPS estimates and maintain our Buy rating and $105 price target, 17x 2025E EBITDA, following strong 2Q24 results with sales and... More



